Recent changes in the H-1B visa program have left biotech employers shorthanded and confused.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Sevier, E.D. & Dahms, A.S. Nat. Biotechnol. 20, 955–956 (2002).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dahms, A., Trow, S. US biotechnology companies and foreign nationals: the changing dynamics of access to H-1B visas. Nat Biotechnol 23, 629–630 (2005). https://doi.org/10.1038/nbt0505-629
Issue Date:
DOI: https://doi.org/10.1038/nbt0505-629